No Stoma VS Ghost Stoma in Patients Undergoing Total Mesorectal Excision for Rectal Cancer
ConditionRectal Neoplasms
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
Sponsorfan li
About this trial
This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy group versus no ileostomy group after total mesorectal excision for rectal cancer.
Eligibility criteria
Qualifiers
Pathologically confirmed rectal cancer.
age ≥18 years and ≤80 years.
intraoperative ghost ileostomy or no stoma was performed.
Disqualifiers
ASA score >3.
Patients with coexisting complete intestinal obstruction.
History of long-term use of immunosuppressive drugs or glucocorticoids.
Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2.
Trial design
Treatments tested in this trial
- Ghost ileostomy
- No ileostomy
Treatment groups
500 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
fan li
Lead sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Sponsor institution
Source ClinicalTrials.gov